CELH
New offense, same energy drink
Celsius just got a fresh Buy rating, and the thesis is pretty simple: the stock looks like it’s priced for a lot less growth than it could actually deliver. The analyst points to an attractive 5.3% free cash flow yield and says the market is basically assuming realistic annual residual growth of 4.3% against a 9.6% weighted average cost of capital.
The acquisition hangover may be temporary
Here’s the key investor question: is Celsius losing steam, or is it just digesting its recent acquisitions? The note lands on the second answer. Brand revenue has slipped recently, but the analyst says that’s more about consolidation after the deal-making than some deeper crack in the business.
Meanwhile, the broader portfolio looks healthier than the headline might suggest. U.S. tracked retail sales for the total portfolio were up 31% in Q2, which is a pretty loud way of saying consumers didn’t suddenly forget how to buy a neon can.
The real prize is outside the U.S.
The long-term bull case is international expansion. Management wants non-U.S. revenue to top 15% by 2031, and that’s the kind of target that makes investors start drawing Monster Beverage comparisons in the margins of their notebooks.
- If the overseas push works, Celsius gets a much bigger runway.
- If it stalls, the stock gets stuck trying to prove the acquisitions were worth it.
Big picture: this isn’t a “new soda flavor” story. It’s a “can Celsius turn a domestic hype brand into a global shelf-space machine?” story.